ShangBay Capital is a venture capital firm established in 2015 and based in Palo Alto, California. The firm specializes in early-stage investments within the medical device, biotechnology, and healthcare technology sectors. With a combined experience of over 100 years, ShangBay Capital's leadership team has cultivated strong relationships with strategic partners and innovators in disruptive technologies.

Their investment philosophy focuses on supporting founders who address significant unmet clinical needs with novel solutions, aiming to generate favorable returns by satisfying large market demands.